Perrigo (PRGO) Accumulated Expenses (2013 - 2026)
Perrigo (PRGO) reported Accumulated Expenses of $153.5 million for Q1 2026, down 39.52% year-over-year from $253.8 million in Q1 2025, and up 36.81% quarter-over-quarter from $112.2 million in Q4 2025.
Perrigo (PRGO) Accumulated Expenses (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Accumulated Expenses data on file, last reported at $153.5 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $153.5 million, down 39.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.5 million (down 39.52% YoY), and the FY2025 annual result was $112.2 million, down 15.83% from the prior year.
- Accumulated Expenses rose to $153.5 million in Q1 2026 per PRGO's latest filing, from $112.2 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $327.9 million in Q2 2025 and troughed at $88.6 million in Q2 2022.
- A 5-year average of $169.9 million and a median of $153.5 million in 2026 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses plunged 66.93% in 2022, then soared 207.0% in 2023.
- A 5-year view of Accumulated Expenses shows it stood at $250.2 million in 2022, then slumped by 34.65% to $163.5 million in 2023, then retreated by 18.47% to $133.3 million in 2024, then dropped by 15.83% to $112.2 million in 2025, then surged by 36.81% to $153.5 million in 2026.
- Business Quant data shows PRGO's Accumulated Expenses at $153.5 million in Q1 2026, $112.2 million in Q4 2025, and $109.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 153.50 Mn |
| Dec 31, 2025 | 112.20 Mn |
| Sep 27, 2025 | 109.90 Mn |
| Jun 28, 2025 | 327.90 Mn |
| Mar 29, 2025 | 253.80 Mn |
| Dec 31, 2024 | 133.30 Mn |
| Sep 28, 2024 | 137.80 Mn |
| Jun 29, 2024 | 218.50 Mn |
| Mar 30, 2024 | 114.40 Mn |
| Dec 31, 2023 | 163.50 Mn |
| Sep 30, 2023 | 156.30 Mn |
| Jul 1, 2023 | 174.30 Mn |
| Apr 1, 2023 | 272.00 Mn |
| Dec 31, 2022 | 250.20 Mn |
| Oct 1, 2022 | 118.10 Mn |
| Jul 2, 2022 | 104.10 Mn |
| Apr 2, 2022 | 88.60 Mn |
| Dec 31, 2021 | 125.60 Mn |
| Oct 2, 2021 | 106.60 Mn |
| Jul 3, 2021 | 132.60 Mn |